ERENUMAB\ERENUMAB-AOOE: 231 Adverse Event Reports & Safety Profile
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
231
Total FAERS Reports
106 (45.9%)
Deaths Reported
102
Hospitalizations
231
As Primary/Secondary Suspect
94
Life-Threatening
95
Disabilities
First Report: 20180101 · Latest Report: 20241226
What Are the Most Common ERENUMAB\ERENUMAB-AOOE Side Effects?
#1 Most Reported
Off label use
70 reports (30.3%)
#2 Most Reported
Device difficult to use
62 reports (26.8%)
#3 Most Reported
Pain
59 reports (25.5%)
All ERENUMAB\ERENUMAB-AOOE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 70 | 30.3% | 58 | 55 |
| Device difficult to use | 62 | 26.8% | 0 | 3 |
| Pain | 59 | 25.5% | 49 | 46 |
| Pemphigus | 57 | 24.7% | 57 | 47 |
| Rheumatoid arthritis | 57 | 24.7% | 57 | 47 |
| Systemic lupus erythematosus | 56 | 24.2% | 56 | 46 |
| Drug ineffective | 55 | 23.8% | 40 | 37 |
| Psoriatic arthropathy | 54 | 23.4% | 54 | 44 |
| Drug dose omission by device | 53 | 22.9% | 0 | 3 |
| Infusion related reaction | 53 | 22.9% | 53 | 43 |
| Migraine | 53 | 22.9% | 25 | 25 |
| Synovitis | 53 | 22.9% | 53 | 46 |
| Type 2 diabetes mellitus | 52 | 22.5% | 52 | 42 |
| Pericarditis | 51 | 22.1% | 51 | 47 |
| Contraindicated product administered | 50 | 21.7% | 44 | 34 |
| Folliculitis | 49 | 21.2% | 49 | 38 |
| Bursitis | 48 | 20.8% | 48 | 37 |
| Hypoaesthesia | 48 | 20.8% | 45 | 34 |
| Swelling | 48 | 20.8% | 48 | 45 |
| Onychomadesis | 47 | 20.4% | 47 | 38 |
Who Reports ERENUMAB\ERENUMAB-AOOE Side Effects? Age & Gender Data
Gender: 96.0% female, 4.0% male. Average age: 47.8 years. Most reports from: CA. View detailed demographics →
Is ERENUMAB\ERENUMAB-AOOE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2018 | 1 | 0 | 0 |
| 2020 | 1 | 0 | 0 |
| 2022 | 2 | 0 | 0 |
| 2023 | 3 | 0 | 0 |
| 2024 | 87 | 0 | 6 |
What Is ERENUMAB\ERENUMAB-AOOE Used For?
| Indication | Reports |
|---|---|
| Migraine | 163 |
| Product used for unknown indication | 48 |
| Rheumatoid arthritis | 15 |
| Migraine prophylaxis | 9 |
ERENUMAB\ERENUMAB-AOOE vs Alternatives: Which Is Safer?
ERENUMAB\ERENUMAB-AOOE vs ERGOCALCIFEROL
ERENUMAB\ERENUMAB-AOOE vs ERGOCALCIFEROL\PHYTONADIONE\RETINOL\TOCOPHEROL
ERENUMAB\ERENUMAB-AOOE vs ERIBULIN
ERENUMAB\ERENUMAB-AOOE vs ERLOTINIB
ERENUMAB\ERENUMAB-AOOE vs ERTAPENEM
ERENUMAB\ERENUMAB-AOOE vs ERTUGLIFLOZIN PIDOLATE
ERENUMAB\ERENUMAB-AOOE vs ERYTHROMYCIN
ERENUMAB\ERENUMAB-AOOE vs ERYTHROMYCIN ETHYLSUCCINATE
ERENUMAB\ERENUMAB-AOOE vs ERYTHROMYCIN LACTOBIONATE
ERENUMAB\ERENUMAB-AOOE vs ERYTHROPOIETIN
Official FDA Label for ERENUMAB\ERENUMAB-AOOE
Official prescribing information from the FDA-approved drug label.